Wang Dai-zhong, Zhang Xiang-hong, Wu Wen-xin, Ma Yu-mei, Cui Ai-rong, Liu Wei-na, Li Xue-min
Department of Pathology, the Second Hospital of Hebei Medical University, Shijiazhuang 050017, China.
Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):446-9. doi: 10. 3760/cma.j.issn.0253-3766.2012.06.010.
To evaluate the H. pylori and Epstein-Barr virus infection in cardiac and distal gastric adenocarcinoma tissues in residents in Cixian county, a high risk area of esophageal cancer in Hebei province, and to explore the putative role of H. pylori and Epstein-Barr virus infection in the carcinogenesis of adenocarcinoma at different subsites of stomach.
H. pylori and Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) immunopositivities were determined by Elivision(TM) plus immunohistochemical staining in 190 gastric adenocarcinoma tissues including 144 cases of cardiac adenocarcinoma and 46 cases of distal gastric adenocarcinoma. The relationship between H. pylori and Epstein-Barr virus infection and the subsite, Laurén type as well as other clinicopathological features of gastric adenocarcinoma were analyzed.
No significant difference was found between the H. pylori detection rates in cardiac and distal gastric adenocarcinomas(56.9% vs. 65.2%, P > 0.05). The detection rate of H. pylori in intestinal type was significantly higher than that in the diffuse type distal gastric adenocarcinomas (71.8% vs. 28.6%, P < 0.05). No positive expression of EBV-LMP1 was found in the gastric adenocarcinomas in this study.
No significant differences in H. pylori and EBV-LMP1 infections were found between cardiac and distal gastric adenocarcinomas in Cixian county. H. pylori infection is related with the intestinal type of distal gastric adenocarcinoma.
评估河北省食管癌高发区磁县居民贲门和远端胃腺癌组织中的幽门螺杆菌(H. pylori)和爱泼斯坦-巴尔病毒(Epstein-Barr virus,EBV)感染情况,并探讨H. pylori和EBV感染在胃不同部位腺癌发生中的潜在作用。
采用Elivision™ plus免疫组织化学染色法检测190例胃腺癌组织(包括144例贲门腺癌和46例远端胃腺癌)中的H. pylori和EBV潜伏膜蛋白1(EBV-LMP1)免疫阳性情况。分析H. pylori和EBV感染与胃腺癌的部位、Laurén分型以及其他临床病理特征之间的关系。
贲门腺癌和远端胃腺癌的H. pylori检出率无显著差异(56.9%对65.2%,P>0.05)。肠型远端胃腺癌的H. pylori检出率显著高于弥漫型(71.8%对28.6%,P<0.05)。本研究中胃腺癌组织未发现EBV-LMP1阳性表达。
磁县贲门腺癌和远端胃腺癌的H. pylori和EBV-LMP1感染无显著差异。H. pylori感染与远端胃腺癌的肠型有关。